Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02411318 · ClinicalTrials.gov registry record · NA
Influence of Lifestyle Factors on Neutrophil Migration Pilot Study
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT02411318 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 47 participants.
The verdict
NCT02411318, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
This study will determine how common lifestyle practices affect the behavior of neutrophils (a type of immune cell) at shorter time scales than previously possible.
Interventions
- BEHAVIORAL Exercise
- DRUG ProLab 200mg caffeine capsule
- OTHER Ethanol ingestion
- DRUG Glucose Tolerance Drink
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2014-09-25 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02411318
The ClinicalTrials.gov registry entry for NCT02411318 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Exercise is the first listed.
NCT02411318 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02411318 about?
NCT02411318 is a clinical study titled "Influence of Lifestyle Factors on Neutrophil Migration Pilot Study". This study will determine how common lifestyle practices affect the behavior of neutrophils (a type of immune cell) at shorter time scales than previously possible.
What is the current status of trial NCT02411318?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2014-09-25. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT02411318?
The interventions under investigation include: Exercise (BEHAVIORAL), ProLab 200mg caffeine capsule (DRUG), Ethanol ingestion (OTHER), Glucose Tolerance Drink (DRUG).
Who is sponsoring clinical trial NCT02411318?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.